GRDN

Guardian Pharmacy Services

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 100%
Negative

Neutral
Business Wire
20 days ago
Guardian Pharmacy Services, Inc. to Participate in Upcoming Raymond James Institutional Investor Conference
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that the company will present at the Raymond James Institutional Investors Conference in Orlando, Florida on Monday, March 2 at 1:40 p.m. Eastern Time. A live audio webcast of the session will be available at https://investors.guardianpharmacy.com. A replay of the webcast will be accessible shortly after the event and will remain available for 90 days. About Guardian Pharmacy Services Guardian Pharmacy Servi.
Guardian Pharmacy Services, Inc. to Participate in Upcoming Raymond James Institutional Investor Conference
Neutral
Business Wire
23 days ago
Guardian Pharmacy Services, Inc., to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will release fourth quarter and full-year 2025 financial results after market close on Wednesday, March 11, 2026. Management will host a conference call to discuss the results at 4:30 p.m. Eastern Time. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing +1 (646) 564-2877 for U.S. participants, o.
Guardian Pharmacy Services, Inc., to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call
Neutral
Seeking Alpha
1 month ago
Guardian Pharmacy Services, Inc. (GRDN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Guardian Pharmacy Services, Inc. (GRDN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Guardian Pharmacy Services, Inc. (GRDN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral
Business Wire
1 month ago
Guardian Pharmacy Services Reiterates 2025 Guidance and Provides 2026 Outlook
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services (NYSE: GRDN), one of the nation's leading long-term care (“LTC”) pharmacy services companies, is reiterating its previously announced 2025 guidance and providing its preliminary financial outlook for 2026. The Company expects to continue its low double-digit adjusted EBITDA growth trajectory in 2026, supported by the strength of its operating model and increased visibility into the year ahead, including anticipated drug pricing changes. The C.
Guardian Pharmacy Services Reiterates 2025 Guidance and Provides 2026 Outlook
Neutral
Business Wire
2 months ago
Guardian Pharmacy Services, Inc. to Participate in Upcoming J.P. Morgan Healthcare Conference
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today confirmed the company will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. The company's leadership team will host investor meetings on Wednesday, January 14th, and present at 4:30 p.m. PT the same day. A live audio webcast of the session will be available at https://investors.guardianpharmacy.com. A replay will be accessible shortly after the event and will remain available for.
Guardian Pharmacy Services, Inc. to Participate in Upcoming J.P. Morgan Healthcare Conference
Positive
MarketBeat
3 months ago
Guardian Pharmacy Stock Pops on Q3 Strength and Upbeat Forecast
Guardian Pharmacy Services Inc. NYSE: GRDN, a small-cap healthcare company, made waves in Tuesday's session after reporting better-than-expected earnings that sent the stock surging on above-average volume.
Guardian Pharmacy Stock Pops on Q3 Strength and Upbeat Forecast
Positive
The Motley Fool
3 months ago
Why Guardian Pharmacy Services Stock Was on a Tear Tuesday
Barely one year after its IPO, the company is doing a decent job finding its niche. This was strongly evidenced by its 20% revenue jump in the third quarter.
Why Guardian Pharmacy Services Stock Was on a Tear Tuesday
Positive
Zacks Investment Research
3 months ago
Guardian Pharmacy Services (GRDN) Q3 Earnings and Revenues Surpass Estimates
Guardian Pharmacy Services (GRDN) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to a loss of $2 per share a year ago.
Guardian Pharmacy Services (GRDN) Q3 Earnings and Revenues Surpass Estimates
Neutral
Seeking Alpha
3 months ago
Guardian Pharmacy Services, Inc. (GRDN) Q3 2025 Earnings Call Transcript
Guardian Pharmacy Services, Inc. ( GRDN ) Q3 2025 Earnings Call November 10, 2025 4:30 PM EST Company Participants Ashley Stockton - Head of Investor Relations & Senior Director Fred Burke - CEO, President & Director David Morris - CFO, Executive VP & Director Conference Call Participants John Ransom - Raymond James & Associates, Inc., Research Division David MacDonald - Truist Securities, Inc., Research Division Raj Kumar - Stephens Inc., Research Division Presentation Operator Good day, everyone, and welcome to Guardian Pharmacy's Third Quarter Earnings Call. [Operator Instructions] I will now hand the call over to Ashley Stockton.
Guardian Pharmacy Services, Inc. (GRDN) Q3 2025 Earnings Call Transcript
Neutral
Business Wire
3 months ago
Guardian Pharmacy Services Reports Third Quarter 2025 Financial Results; Raises Full-Year Guidance
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the third quarter ended September 30, 2025. The Company also raised its full-year revenue and Adjusted EBITDA guidance. Third Quarter Financial Results Revenue of $377.4 million, up 20% year-over-year. Residents served ended the quarter at approximately 204,000, up 13% year-over-year. Net Income (loss).
Guardian Pharmacy Services Reports Third Quarter 2025 Financial Results; Raises Full-Year Guidance